Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
RecruitingOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
March 23, 2022
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Conditions
Lymphoproliferation Induced by HTLV-1HTLV-1 Adult T-cell Lymphoma / LeukemiaHTLV-1 Infection
Trial Locations (1)
75015
RECRUITING
Hôpital Necker Enfants Malades, Paris
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT05237245 - Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS) | Biotech Hunter | Biotech Hunter